Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Shoemaker Daniel D
Chief Scientific Officer at FATE THERAPEUTICS. Filing since 31 Mar 2014.
CIK 0001586892
Company
Date
Role
Action
Shares
Amount
Of holding
FATE
FATE THERAPEUTICS INC
8 Mar 2021
Chief Scientific Officer
Sold, plan not stated
25,000
$2.04M
25.5%
FATE
FATE THERAPEUTICS INC
11 Jan 2021
Chief Scientific Officer
Sold, plan not stated
3,253
$360.48K
3.7%
FATE
FATE THERAPEUTICS INC
8 Jan 2021
Chief Scientific Officer
Sold, plan not stated
6,229
$729.43K
6.7%
FATE
FATE THERAPEUTICS INC
16 Nov 2020
Chief Scientific Officer
Sold, plan not stated
25,000
$1.30M
21.2%
FATE
FATE THERAPEUTICS INC
14 Sep 2020
Chief Scientific Officer
Sold, plan not stated
25,000
$907.54K
17.5%
FATE
FATE THERAPEUTICS INC
8 Jan 2020
Chief Scientific Officer
Sold, plan not stated
5,700
$117.99K
3.8%
FATE
FATE THERAPEUTICS INC
30 Dec 2019
Chief Scientific Officer
Sold, plan not stated
25,000
$487.43K
16.8%
FATE
FATE THERAPEUTICS INC
15 Oct 2019
Chief Scientific Officer
Sold, plan not stated
11,800
$168.59K
8.7%
FATE
FATE THERAPEUTICS INC
27 Jun 2019
Chief Scientific Officer
Sold, plan not stated
12,500
$252.61K
8.4%
FATE
FATE THERAPEUTICS INC
28 Mar 2019
Chief Scientific Officer
Sold, plan not stated
12,500
$211.70K
8.4%
FATE
FATE THERAPEUTICS INC
16 Oct 2017
Chief Scientific Officer
Sold, plan not stated
700
$2.86K
0.8%
FATE
FATE THERAPEUTICS INC
13 Oct 2017
Chief Scientific Officer
Sold, plan not stated
12,525
$48.35K
12.1%
FATE
FATE THERAPEUTICS INC
31 Mar 2014
Chief Technology Officer
Sold, plan not stated
8,653
$85.36K
25.0%
13 decisions on file.
